Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Protein misfolding and clearance in demyelinating peripheral neuropathies: Therapeutic implications.
Review of the biology of multiple sclerosis.
Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.
Does ability to walk reflect general functionality in inflammatory neuropathies?
Pharmacological treatment for memory disorder in multiple sclerosis.
Psychological and Neurobehavioral Disorders in MSA Health-Oriented, Rehabilitative Perspective.
Multiple perspectives on the health service need, use, and variability among older adults with multiple sclerosis.
Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice.
Novel Insights and Therapeutics in Multiple Sclerosis.
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
Behçet's syndrome: a critical digest of the 2012-2013 literature.
Employment needs of people with multiple sclerosis: a review of current literature and application to occupational therapy practice.
Susceptibility Genes for Multiple Sclerosis Identified in a Gene-Based Genome-Wide Association Study.
Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy.
Serum NSE and multiple sclerosis.
An investigation into the association between HLA-G 14bp insertion/deletion polymorphism and multiple sclerosis susceptibility.
Tocilizumab and multiple sclerosis: a causal relationship? Clinical Commentary on the case report entitled - MS arising during Tocilizumab therapy for rheumatoid arthritis.
The Emerging Roles of Gamma-Delta T Cells in Tissue Inflammation in Experimental Autoimmune Encephalomyelitis.
Anti-CD20 antibody wows in multiple sclerosis.
Small Molecule Inhibitor of Antigen Binding and Presentation by HLA-DR2b as a Therapeutic Strategy for the Treatment of Multiple Sclerosis.
[Animal models for multiple sclerosis].
ATP-Mediated Compositional Change in Peripheral Myelin Membranes: A Comparative Raman Spectroscopy and Time-Of-Flight Secondary Ion Mass Spectrometry Study.
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.
Systematic network lesioning reveals the core white matter scaffold of the human brain.

Pages